Tenaya Therapeutics Inc (TNYA)

Aug 08, 2025

Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire

Aug 08, 2025

Aug 08, 2025

Heart Disease Cure? Tenaya CEO Reveals Latest Therapeutic Developments at Major Growth Conference - Stock Titan

Aug 08, 2025

Aug 07, 2025

Tenaya Therapeutics shares rise 6.67% premarket after positive safety reviews for TN-201 and TN-401 gene therapy trials. - AInvest

Aug 07, 2025

Aug 07, 2025

Tenaya Therapeutics Posts Smaller Losses And Advances Gene Trials - Finimize

Aug 07, 2025

Aug 07, 2025

Tenaya (TNYA) Q2 Loss Narrows 59% - The Globe and Mail

Aug 07, 2025

Aug 06, 2025

Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times

Aug 06, 2025

Aug 06, 2025

Tenaya's Gene Therapies Clear Key Safety Hurdles: Q4 Data Readouts Coming for Heart Disease Treatments - Stock Titan

Aug 06, 2025

Aug 03, 2025

What are the technical indicators suggesting about Tenaya Therapeutics Inc.Achieve consistent profits with proven methods - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What analysts say about Tenaya Therapeutics Inc. stockPhenomenal wealth increase - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Why is Tenaya Therapeutics Inc. stock attracting strong analyst attentionCapitalize on fast-moving stock opportunities - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Tenaya Therapeutics Inc. company’s balance sheetMaximize your gains with professional insights - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Does Tenaya Therapeutics Inc. stock perform well during market downturnsMarket-beating returns - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What are the latest earnings results for Tenaya Therapeutics Inc.Market-leading capital gains - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What is Tenaya Therapeutics Inc. company’s growth strategyCapitalize on market shifts before others do - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What makes Tenaya Therapeutics Inc. stock price move sharplyMaximize gains with timely market signals - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What is the dividend policy of Tenaya Therapeutics Inc. stockBoost your wealth with consistent growth stocks - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How sentiment analysis helps forecast Tenaya Therapeutics Inc.ROI Focused Setup Screener With Exit Markers - Newser

Aug 02, 2025

Aug 02, 2025

Can Tenaya Therapeutics Inc. hit a new high this monthMarket Opportunity Tracker for Swing Traders - Newser

Aug 02, 2025

Aug 02, 2025

Is Tenaya Therapeutics Inc. stock bottoming outVolume Confirmed Setup with Entry Confidence - Newser

Aug 02, 2025

Aug 02, 2025

How to read the order book for Tenaya Therapeutics Inc.Free Consistent Profit Pattern Recognition Tools - Newser

Aug 02, 2025

Aug 01, 2025

Advanced analytics toolkit walkthrough for Tenaya Therapeutics Inc.Technical Confirmation System with Signal Alerts - Newser

Aug 01, 2025

Aug 01, 2025

How does Tenaya Therapeutics Inc. generate profit in a changing economyChart Pattern Strategy To Watch Now - Jammu Links News

Aug 01, 2025

Aug 01, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of “Buy” from Analysts - Defense World

Aug 01, 2025

Aug 01, 2025

Using economic indicators to assess Tenaya Therapeutics Inc. potentialReal Market Tracker with Price Action Tools - Newser

Aug 01, 2025

Aug 01, 2025

Will Tenaya Therapeutics Inc. stock go up soonFundamental Forecast for Undervalued Stocks - Newser

Aug 01, 2025

Aug 01, 2025

What institutions are buying Tenaya Therapeutics Inc. stock nowFundamental Forecast for Undervalued Stocks - Newser

Aug 01, 2025

Jul 31, 2025

Intrinsic Value of Tenaya Therapeutics Inc. Stock: Is It Undervalued or OvervaluedDaily Breakout List with Smart Filters - Newser

Jul 31, 2025

Jul 31, 2025

Kalaris Therapeutics shares rise 1.49% intraday after Tenaya Therapeutics, Inc. received positive safety endorsements for its cardiovascular gene therapy clinical trials. - AInvest

Jul 31, 2025

Jul 30, 2025

Published on: 2025-07-30 22:05:21 - metal.it

Jul 30, 2025

Jul 30, 2025

Tenaya Receives Positive Safety Reviews from Independent - GlobeNewswire

Jul 30, 2025

Jul 30, 2025

Tenaya Therapeutics stock rises after positive safety reviews for heart gene therapies By Investing.com - Investing.com South Africa

Jul 30, 2025

Jul 30, 2025

Tenaya Therapeutics stock rises after positive safety reviews for heart gene therapies - Investing.com Nigeria

Jul 30, 2025

Jul 30, 2025

Gene Therapy's Cardiovascular Revolution: Why Tenaya Therapeutics Is a High-Conviction Bet in 2025 - AInvest

Jul 30, 2025

Jul 30, 2025

Tenaya completes enrollment in both dose cohorts for HCM gene therapy - Investing.com

Jul 30, 2025

Jul 30, 2025

Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed - The Manila Times

Jul 30, 2025

Jul 30, 2025

Breakthrough: Tenaya's Dual Heart Disease Gene Therapies Pass Major Safety Milestone - Stock Titan

Jul 30, 2025

Jul 30, 2025

How Resilient Is Tenaya Therapeutics Inc. Stock During Economic DownturnsEarly Buy Opportunity with Chart Triggers - Newser

Jul 30, 2025

Jul 29, 2025

Will earnings trigger a reversal in Tenaya Therapeutics Inc.Real-Time AI Entry Forecast Generator - Newser

Jul 29, 2025

Jul 29, 2025

What analysts say about Tenaya Therapeutics Inc. stock outlookEntry Optimization Tool with Screener Logic - Newser

Jul 29, 2025

Jul 29, 2025

Analyzing net buyer seller activity in Tenaya Therapeutics Inc.Free Reversal Alert Based on RSI Indicator - Newser

Jul 29, 2025

Jul 28, 2025

Is it the right time to buy Tenaya Therapeutics Inc. stockEarnings Report Insights With Low Risk - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

How Tenaya Therapeutics Inc. stock performs during market volatilityFree AI Screening for Swing Trade Picks - Newser

Jul 28, 2025